Cargando…

Vaccination against RSV: Is maternal vaccination a good alternative to other approaches?

The respiratory syncytial virus (RSV) is the major cause of lower respiratory tract illness (LRI) in infants worldwide. Also persons with heart/lung disease or an immunodeficiency disorder, and the elderly are at increased risk for severe LRI upon RSV infection. Although there is at present no licen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaaijk, Patricia, Luytjes, Willem, Rots, Nynke Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901815/ https://www.ncbi.nlm.nih.gov/pubmed/23442726 http://dx.doi.org/10.4161/hv.24096

Ejemplares similares

Vaccination against Lyme disease: Are we ready for it?
por: Kaaijk, Patricia, et al.
Publicado: (2015)

Routine vaccination against MenB: Considerations for implementation
por: Kaaijk, Patricia, et al.
Publicado: (2014)

Are we prepared for emerging flaviviruses in Europe? Challenges for vaccination
por: Kaaijk, Patricia, et al.
Publicado: (2017)

Parents’ attitude toward multiple vaccinations at a single visit with alternative delivery methods
por: Kaaijk, Patricia, et al.
Publicado: (2014)

Impact of vaccination during pregnancy on infants’ immune responses to vaccinations- definitions and statistical approaches
por: Maertens, Kirsten, et al.
Publicado: (2022)

Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands
por: Kaaijk, Patricia, et al.
Publicado: (2012)

1633. Willingness to receive maternal RSV vaccine and infant monoclonal RSV antibody
por: Gidengil, Courtney, et al.
Publicado: (2023)

Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age
por: Jans, Jop, et al.
Publicado: (2017)

Contribution of Influenza Viruses, Other Respiratory Viruses and Viral Co-Infections to Influenza-like Illness in Older Adults
por: Kaaijk, Patricia, et al.
Publicado: (2022)

SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals
por: Emmelot, Maarten E., et al.
Publicado: (2022)

Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals
por: Emmelot, Maarten E., et al.
Publicado: (2022)

Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity
por: Rosendahl Huber, Sietske K., et al.
Publicado: (2019)

Are good intentions putting the vaccination ecosystem at risk?
por: Watson, Michael, et al.
Publicado: (2016)

Current Insights in the Development of Efficacious Vaccines Against RSV
por: Soto, Jorge A., et al.
Publicado: (2020)

Commentary: The good vaccine, the bad virus, and the ugly inflammation
por: Dutta Majumder, Parthopratim
Publicado: (2023)

The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models
por: Baral, Ranju, et al.
Publicado: (2020)

2770. Intrapulmonary Vaccination with an M Protein-Deficient Respiratory Syncytial Virus (RSV) Vaccine Protects Infant Baboons Against an RSV Challenge
por: Welliver, Robert C, et al.
Publicado: (2019)

Differential B-Cell Memory Around the 11-Month Booster in Children Vaccinated With a 10- or 13-Valent Pneumococcal Conjugate Vaccine
por: van Westen, Els, et al.
Publicado: (2015)

Fusing safety and efficacy: A maternal bivalent RSV prefusion F vaccine
por: Miller, Ann M., et al.
Publicado: (2023)

M Protein-Deficient Respiratory Syncytial Virus (RSV) Vaccine Protects Infant Baboons Against RSV Challenge
por: Welliver, Robert C, et al.
Publicado: (2017)

Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine
por: Krause, Anja, et al.
Publicado: (2011)

Nucleic acid-based vaccines targeting respiratory syncytial virus: Delivering the goods
por: Smith, Trevor R. F., et al.
Publicado: (2017)

Mandatory vaccination: understanding the common good in the midst of the global polio eradication campaign
por: Gostin, Lawrence O.
Publicado: (2018)

Correlative outcomes of maternal immunization against RSV in cotton rats
por: Blanco, Jorge C. G., et al.
Publicado: (2022)

The gift of preexisting immunity for developing an alternative vaccine strategy
por: Tran, Kim A., et al.
Publicado: (2023)

Vaccination against COVID‐19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders
por: Kaczmarek, Radoslaw, et al.
Publicado: (2021)

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
por: Cox, Freek, et al.
Publicado: (2023)

2781. Statistical Modeling to Predict Maternal RSV Vaccine Efficacy from Neutralizing Titers
por: Cai, Bing, et al.
Publicado: (2019)

A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection
por: Endt, Kathrin, et al.
Publicado: (2022)

ChAd155-RSV vaccine is immunogenic and efficacious against bovine RSV infection-induced disease in young calves
por: de Jong, Rineke, et al.
Publicado: (2022)

RSV awareness, risk perception, causes, and terms: Perspectives of pregnant and lactating women in Kenya to inform demand generation efforts for maternal RSV vaccines
por: Limaye, Rupali J., et al.
Publicado: (2023)

Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal()
por: Chu, Helen Y., et al.
Publicado: (2017)

Caring for the Vaccine-Hesitant Family: Evidence-Based Alternatives to Dismissal
por: Williams, Joshua T.B., et al.
Publicado: (2020)

Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model
por: Fuentes, Sandra, et al.
Publicado: (2017)

Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting
por: Campbell, Patricia T., et al.
Publicado: (2020)

First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector–Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults
por: Cicconi, Paola, et al.
Publicado: (2020)

The Italian arm of the PREPARE study: an international project to evaluate and license a maternal vaccine against group B streptococcus
por: Berardi, Alberto, et al.
Publicado: (2020)

Monkeypox (Mpox) vaccines and their side effects: the other side of the coin
por: Sah, Ranjit, et al.
Publicado: (2023)

Shedding Light on the Role of the Skin in Vaccine-Induced Protection against the Malaria Sporozoite
por: Daily, Johanna Patricia
Publicado: (2018)

Interactions between RSV Infection, Asthma, and Atopy: Unraveling the Complexities
por: Holt, P.G., et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_fbr44bq5o038c267g8bnc2sdpt